| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.071 | 0.2 |